Weight Loss Injections and Epilepsy: Key Considerations Before You Start

Step 1: Understand why gastric emptying matters for your AEDs

GLP-1 receptor agonists like semaglutide, and dual GIP/GLP-1 agonists like tirzepatide, slow the rate at which food and liquid leave the stomach. That is partly how they reduce appetite and blood sugar. The knock-on effect, though, is that oral medicines taken around the same time can be absorbed more slowly or, in some cases, less completely. For most people on a stable drug regimen this is a minor consideration. For someone whose seizure control depends on maintaining steady blood levels of an AED, even a modest shift in absorption can matter.

Anti-epileptic drugs vary widely in how sensitive they are to absorption changes. Medicines with a narrow therapeutic index (where the difference between a therapeutic dose and either an ineffective or toxic one is small) warrant closer attention. Lamotrigine, levetiracetam, sodium valproate and carbamazepine are among the AEDs commonly prescribed in the UK; each has a different pharmacokinetic profile. Your prescriber and your epilepsy team are best placed to assess whether your particular AED carries meaningful risk in this context. This is not a reason to rule out weight loss injections outright; it is a reason to ensure the conversation happens before, not after, you start.

Semaglutide's prescribing information, available via the electronic Medicines Compendium, discusses the potential for delayed absorption of co-administered oral medicines and recommends caution. The same principle applies to tirzepatide.

Step 2: Tell both your prescriber and your epilepsy team, before the first pen arrives

This is the practical step that matters most. A GLP-1 prescriber at a service like an online pharmacy will ask about your current medicines during your consultation; it is important to list every AED, including the strength and dosing schedule. Being complete here is not bureaucracy, it is what allows the prescriber to assess whether treatment is appropriate and, if so, whether any monitoring needs to be built in.

Equally, your neurologist or epilepsy nurse should know if you plan to start a GLP-1 medicine. Weight loss itself can affect seizure control in some people. Body weight influences the distribution of certain drugs, and if you lose a meaningful amount of weight over weeks or months, the effective dose of a weight-dependent AED may shift. This is not inevitable, and it does not apply equally to all AEDs, but it is worth flagging so your team can decide whether blood level monitoring or a dose review is sensible alongside your weight loss treatment. It is also worth knowing that weight loss injections can sometimes be associated with hair loss, so your team can keep an eye on that alongside any changes to your AED levels.

You might also find it helpful to read about how weight loss injections work more broadly before your consultation, so you can ask informed questions about your own situation.

Step 3: Practical considerations once treatment is underway

If a prescriber decides that tirzepatide or semaglutide is appropriate for you, a few practical points are worth keeping in mind as treatment begins. Both medicines are given as once-weekly subcutaneous injections, typically in the abdomen, thigh or upper arm, with the injection site rotated each week. Treatment starts at a low dose (2.5 mg for tirzepatide) and increases gradually over months under prescriber oversight. That slow titration also means any effect on AED absorption builds gradually, giving your clinical team time to spot and respond to changes.

If you notice any change in your seizure frequency or character after starting a weight loss injection, tell your epilepsy team promptly and let your prescribing pharmacy know. It may be entirely unrelated; it may warrant a medication review. Either way, the information is important. The gastrointestinal side effects common with these medicines (nausea, reduced appetite, occasional vomiting) can transiently affect how consistently you absorb your AEDs on any given day, particularly early in treatment when GI effects tend to be strongest.

Women with epilepsy who rely on oral contraceptives should be aware that tirzepatide specifically requires an additional non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase. The NHS England guidance on weight management injections covers this, and semaglutide does not carry the same evidence of reduced pill effectiveness, though discussing contraception with your prescriber is always sensible given the pregnancy exclusion that applies to both medicines.

Eligibility and what to expect from a clinical review at nume

People with epilepsy are not automatically excluded from tirzepatide or semaglutide treatment. The licensed criteria for private prescribing are a BMI of 30 or above, or 27 or above alongside a weight-related health condition. Epilepsy itself is not listed as a disqualifying condition in the SmPCs, but certain other medical factors (severe gastrointestinal disease, a history of pancreatitis, pregnancy, or being under 18) do preclude prescribing. Some patients also ask whether NAD injections have a role in weight loss alongside these treatments, and your full health picture, including your epilepsy medications, is what the prescriber weighs up.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, not automated software. If your circumstances need careful thought (and a complex medication list is exactly that) a real clinician reads your answers the same day. If you are curious about how the wider process works, our FAQs cover the consultation steps in plain terms. For those managing other health conditions alongside weight, the guide to PCOS and weight loss injections and our overview of weight loss injections and MS show how condition-specific factors are approached. If questions arise once you are a patient, our team is available seven days a week.

When your treatment is approved and dispatched, it arrives via DPD the next working day in plain, unbranded packaging, the pen itself is clearly labelled with your name and dosing instructions, so there is nothing to puzzle over when you open the box.